AstraZeneca Pharma India Limited (BOM:506820)

AstraZeneca Pharma India Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	3,999	5,361	5,056	5,003	4,484	3,523
Cash & Short-Term Investments	3,999	5,361	5,056	5,003	4,484	3,523
Cash Growth	-19.49%	6.05%	1.04%	11.58%	27.27%	39.54%
Accounts Receivable	2,202	1,849	1,531	1,075	858.9	851.9
Other Receivables	-	143.6	160.4	105.1	121.8	56.6
Receivables	2,204	1,995	1,693	1,181	981.6	911.2
Inventory	7,786	5,485	2,279	1,902	1,402	1,598
Prepaid Expenses	-	142.1	109.6	117.7	108.2	83.9
Other Current Assets	565.6	439.6	190	150.4	80.5	71.1
Total Current Assets	14,555	13,424	9,327	8,355	7,057	6,188
Property, Plant & Equipment	397.9	635.8	648.4	701.9	766.9	849.8
Other Intangible Assets	-	6.6	21.1	-	-	-
Long-Term Deferred Tax Assets	451	415.6	212.5	206.7	163	145.3
Other Long-Term Assets	740.8	698.6	568.5	576.6	574.9	560.1
Total Assets	16,146	15,181	10,780	9,849	8,566	7,747
Accounts Payable	5,509	4,563	1,965	2,279	1,904	1,784
Accrued Expenses	-	602.7	767.2	852.3	785.3	736.6
Current Portion of Leases	69.1	62.8	18.1	35.2	36.1	35.1
Current Income Taxes Payable	132.2	106.4	66.6	24.2	49.4	56.3
Current Unearned Revenue	-	722.4	490.5	398	306.9	128.3
Other Current Liabilities	2,064	972.7	263.7	250.8	244.4	295
Total Current Liabilities	7,774	7,030	3,571	3,839	3,327	3,035
Long-Term Leases	278.8	294.5	27.8	36.9	50.2	86.3
Pension & Post-Retirement Benefits	-	53.7	44.4	69	48.2	40.8
Other Long-Term Liabilities	102.5	99.5	17.7	16.6	26.8	23.3
Total Liabilities	8,156	7,478	3,661	3,962	3,452	3,185
Common Stock	50	50	50	50	50	50
Retained Earnings	-	6,859	6,313	5,088	4,321	3,772
Comprehensive Income & Other	7,940	795	756.4	749.2	743	739.4
Shareholders' Equity	7,990	7,704	7,119	5,887	5,114	4,562
Total Liabilities & Equity	16,146	15,181	10,780	9,849	8,566	7,747
Total Debt	347.9	357.3	45.9	72.1	86.3	121.4
Net Cash (Debt)	3,652	5,004	5,010	4,931	4,398	3,402
Net Cash Growth	-23.87%	-0.11%	1.59%	12.13%	29.27%	41.36%
Net Cash Per Share	146.10	200.16	200.39	197.25	175.92	136.08
Filing Date Shares Outstanding	25	25	25	25	25	25
Total Common Shares Outstanding	25	25	25	25	25	25
Working Capital	6,781	6,394	5,756	4,515	3,730	3,153
Book Value Per Share	319.63	308.14	284.77	235.48	204.56	182.47
Tangible Book Value	7,990	7,697	7,098	5,887	5,114	4,562
Tangible Book Value Per Share	319.63	307.88	283.92	235.48	204.56	182.47
Land	-	4.9	4.9	4.9	4.9	4.9
Buildings	-	427	427	421.3	415.2	383.4
Machinery	-	1,155	1,208	1,154	1,082	1,023
Construction In Progress	-	-	2.7	13.3	22	40.2

Source: S&P Global Market Intelligence. Standard template. Financial Sources.